Skip Ribbon Commands
Skip to main content

Dr Wong Jolene

Dr Wong Jolene

MBBS, MMED, FRCS Ed (Gen Surg)

Associate Consultant

National Cancer Centre Singapore

Specialty: Surgical Oncology

Sub-specialties: Peritoneal-based Malignancies, Sarcoma, Skin & Melanoma, Upper Gastrointestinal

Conditions Treated by this Doctor:
Peritoneal based Malignancies, Sarcoma and Melanoma, Upper Gastrointestinal Cancers.

Clinical Appointments

  • Associate Consultant Sarcoma, Peritoneal and Rare Tumours (SPRinT) National Cancer Centre SingaporeNational Cancer Centre Singapore
  • Visiting Consultant KK Women's and Children's HospitalKK Women's and Children's Hospital

Academic Appointments

  • Clinical Lecturer & Tutor, Duke-NUS Medical School
  • Clinical Lecturer & Tutor, Yong Loo Lin School of Medicine, National University of Singapore
  • Adjunct Teaching faculty, Lee Kong Chian School of Medicine
  • Clinical Physician Faculty Member, SingHealth General Surgery Residency Programme


Dr Jolene Wong is an Associate Consultant at the Department of Sarcoma, Peritoneal and Rare Tumours (SPRinT).  She graduated from the NUS Yong Loo Lin School of Medicine with consecutive Dean’s list awards between 2010 to 2014 and was subsequently selected to enter the Singhealth General Residency Programme, successfully completing her specialist training in 2019. She is a fellow of the Royal College of Surgeons, Edinburgh and holds a Master of Medicine (Surgery). Dr Wong is also a certified medical graduate of the United States Medical Licensing Examination (USMLE).

Dr Wong’s clinical area of expertise include peritoneal surface based malignancies, sarcomas, melanomas, and gastro-intestinal tumours. She has authored several scientific publications in regional and international journals and has delivered multiple scientific presentations at conferences worldwide. With a strong interest in clinical research, Dr Wong was awarded the Singapore General Hospital Academic Clinical Programme (SGH ACP) seed grant, the National Cancer Centre (NCC) Research Fund (NCCRF) and NCCS Cancer Fund (Research) in 2020 for her pilot clinical trial on Pressurised Intra-peritoneal Aerosolised Chemotherapy (PIPAC) in peritoneal metastases.

Beyond her clinical and research responsibilities, Dr Wong is a strong believer of volunteerism and philanthropy in medicine and spearheaded the development of the NUS-Neighbourhood health screening (NHS) programme, serving has the chairperson from 2011-2012.  As an advisory committee member of the Cancer Education and Information Services aimed at providing personalised cancer education and treatment to cancer patients, she hopes that a synergy of good clinical research and a philanthropic spirit  will serve as platforms to better the outcomes of oncological patients worldwide.

Dr Wong is also active and passionate about medical education and training, and is a clinician faculty member of the Singhealth General Surgery Residency Programme and a clinical tutor to students from NUS, Duke and NTU.


  • FRCS (Edinburgh), August 2019
  • ECFMG (USA), January 2019
  • Master of Medicine (Surgery), July 2017
  • MRCS (Edinburgh), October 2016
  • National University of Singapore, Bachelor of Medicine and Bachelor of Surgery, 2009-2014

Professional Appointments and Committee Memberships


Research Interests

  • Peritoneal Carcinomatosis
  • Retroperitoneal sarcoma
  • Surgical Innovations
  • Pelvic Malignancies


  • Ong C-AJ*, Lim HJ*, Tan JWS, Wong JSM, Lim ST, Kwek JW, Tan HK, Hwang WYK, Chia CS (* Equal contribution). Facilitating timely cancer care in a surgical oncology subspecialty unit during the pandemic and recovery phase of the COVID era. Asian J Surg. 2020. JIF: 1.560.
  • Wong JSM, Tan GHC, Chia CS, Ong CAJ, Teo MCC. Management of Synchronous Lateral Pelvic Nodal Metastasis in Rectal Cancer in the era of Neoadjuvant Chemoradiation: A Systemic Review. World J Gastrointest Surg. 2020;12(5): 247-258.
  • Tan G, Wong J. Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer. J Gastrointest Oncol. 2020;11(3): 508-512.
  • Wong J, Tan G, Chia CS, Ong J, Ng WY, Teo MCC. The Importance of Synchronicity in the Management of Colorectal Peritoneal Metastases with Cytoreductive Surgery & Hyperthermic Intraperitoneal Chemotherapy. World J Surg Oncol 2020;18:10. JIF: 1.966.
  • Lee LS , Wong J , Kah AHC, Lee SY, Chan CY, Tan SS, Teo JY, Goh BK. The development of robotic hepatopancreatobiliary surgery in Singapore: a multi-institutional experience. Ann Laparosc Endosc Surg 2018;Jul.
  • Wong J, Tan GHC, Nadarajah R, Teo M. Novel management of a giant cervical myoma in a premenopausal patient. BMJ Case Rep; 2017 Oct 09; 2017.
  • Wong JSM, Tan GHC, Quek R, Goh BKP, Kwok LL, Kumar M, Soo KC, Teo MCC. Is multivisceral resection in locally advanced gastrointestinal stromal tumours an acceptable strategy? ANZ J Surg; 2017 Jun 09; 87(6):477-482. JIF: 1.605.
  • Wong JS, Tan GH, Teo MC. Management of para-aortic lymph node metastasis in colorectal patients: A systemic review. Surg Oncol; 2016 Dec; 25(4):411-418. JIF: 3.00.
  • Tan GH, Wong JS, Quek R, Goh BK, Kwok LL, Pan S, Soo KC, Teo MC. Role of upfront surgery for recurrent gastrointestinal stromal tumours. ANZ J Surg; 2016 Nov 09; 86(11):910-915. JIF: 1.605.
  • Wong J, Tan G,Chia C, Sathiyamoorthy S, Teo M. A Rare Case of Multiple Malignancies arising in Endometriosis: Diffuse Extra-Uterine High-grade Endometrial Stromal Sarcoma and Ovarian Carcinoma. American Journal of Cancer Case Reports 2015, 3:135-142

Research Trials

  • Radical resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma (Ongoing, Study role: Co-I)
  • Pilot Study: Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancers at high risk of developing peritoneal metastases (Ongoing, Study role: Co-I)